These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16426111)

  • 41. The CANMAT task force recommendations for the management of patients with mood disorders and comorbid anxiety disorders.
    Schaffer A; McIntosh D; Goldstein BI; Rector NA; McIntyre RS; Beaulieu S; Swinson R; Yatham LN;
    Ann Clin Psychiatry; 2012 Feb; 24(1):6-22. PubMed ID: 22303519
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: consensus and controversies.
    Yatham LN; Kennedy SH; O'Donovan C; Parikh S; MacQueen G; McIntyre R; Sharma V; Silverstone P; Alda M; Baruch P; Beaulieu S; Daigneault A; Milev R; Young LT; Ravindran A; Schaffer A; Connolly M; Gorman CP;
    Bipolar Disord; 2005; 7 Suppl 3():5-69. PubMed ID: 15952957
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials.
    Solmi M; Veronese N; Zaninotto L; van der Loos ML; Gao K; Schaffer A; Reis C; Normann C; Anghelescu IG; Correll CU
    CNS Spectr; 2016 Oct; 21(5):403-418. PubMed ID: 27686028
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of obsessive-compulsive disorder on the antimanic response to olanzapine therapy in youth with bipolar disorder.
    Joshi G; Mick E; Wozniak J; Geller D; Park J; Strauss S; Biederman J
    Bipolar Disord; 2010 Mar; 12(2):196-204. PubMed ID: 20402712
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.
    Perugi G; Frare F; Toni C; Tusini G; Vannucchi G; Akiskal HS
    Eur Arch Psychiatry Clin Neurosci; 2010 Oct; 260(7):553-60. PubMed ID: 20238120
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An open-label trial of risperidone augmentation for refractory anxiety disorders.
    Simon NM; Hoge EA; Fischmann D; Worthington JJ; Christian KM; Kinrys G; Pollack MH
    J Clin Psychiatry; 2006 Mar; 67(3):381-5. PubMed ID: 16649823
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and safety of quetiapine-XR as monotherapy or adjunctive therapy to a mood stabilizer in acute bipolar depression with generalized anxiety disorder and other comorbidities: a randomized, placebo-controlled trial.
    Gao K; Wu R; Kemp DE; Chen J; Karberg E; Conroy C; Chan P; Ren M; Serrano MB; Ganocy SJ; Calabrese JR
    J Clin Psychiatry; 2014 Oct; 75(10):1062-8. PubMed ID: 25007003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Treatment of acute bipolar disorder. Intriguing balancing act between mania and depression].
    Grunze H; Dittmann S
    MMW Fortschr Med; 2003 May; 145 Suppl 2():27-30. PubMed ID: 14579481
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers.
    Leverich GS; Altshuler LL; Frye MA; Suppes T; McElroy SL; Keck PE; Kupka RW; Denicoff KD; Nolen WA; Grunze H; Martinez MI; Post RM
    Am J Psychiatry; 2006 Feb; 163(2):232-9. PubMed ID: 16449476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of bipolar depression: making sensible decisions.
    Citrome L
    CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Bipolar disorder and personality disorder.
    Bowden C; Maier W
    Eur Psychiatry; 2003 Dec; 18 Suppl 1():9s-12s. PubMed ID: 23573635
    [No Abstract]   [Full Text] [Related]  

  • 52. Mood stabilizers and atypical antipsychotics: bimodal treatments for bipolar disorder.
    Ketter TA; Nasrallah HA; Fagiolini A
    Psychopharmacol Bull; 2006; 39(1):120-46. PubMed ID: 17065977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential clinical characteristics, medication usage, and treatment response of bipolar disorder in the US versus The Netherlands and Germany.
    Post RM; Leverich GS; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Nolen WA; Kupka R; Grunze H; Walden J; Rowe M
    Int Clin Psychopharmacol; 2011 Mar; 26(2):96-106. PubMed ID: 21178634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is anticonvulsant treatment of mania a class effect? Data from randomized clinical trials.
    Rosa AR; Fountoulakis K; Siamouli M; Gonda X; Vieta E
    CNS Neurosci Ther; 2011 Jun; 17(3):167-77. PubMed ID: 20015083
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristics of responders and non-responders to risperidone monotherapy or placebo in co-occurring bipolar disorder and anxiety disorder.
    Seo JS; Jamieson K; Cosgrove V; Gwizdowski IS; Yang H; Sheehan DV; McElroy SL; Suppes T
    Eur Psychiatry; 2013 Mar; 28(3):190-6. PubMed ID: 22130178
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Randomized, placebo-controlled trial of quetiapine XR and divalproex ER monotherapies in the treatment of the anxious bipolar patient.
    Sheehan DV; Harnett-Sheehan K; Hidalgo RB; Janavs J; McElroy SL; Amado D; Suppes T
    J Affect Disord; 2013 Feb; 145(1):83-94. PubMed ID: 22920718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.
    Evins AE
    J Clin Psychiatry; 2003; 64 Suppl 8():9-14. PubMed ID: 12892536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacological treatment of social anxiety disorder: a meta-analysis.
    Blanco C; Schneier FR; Schmidt A; Blanco-Jerez CR; Marshall RD; Sánchez-Lacay A; Liebowitz MR
    Depress Anxiety; 2003; 18(1):29-40. PubMed ID: 12900950
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder.
    Gao K; Kemp DE; Ganocy SJ; Muzina DJ; Xia G; Findling RL; Calabrese JR
    Bipolar Disord; 2008 Dec; 10(8):907-15. PubMed ID: 19594506
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
    Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
    Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.